UPP JPMC CO Request 4 P-25955 Emergent CPO.pdf

Change Order Request for Participation or Piggyback Contract

State of Illinois Chief Procurement Office General Services Change Order Request for Participation or Piggyback Contract v.25.1 Page 1 of 2

Section I - General Information

Requesting Agency CPO GS - Chief Procurement Office General Services

Project Title JPMC MMCAP Narcan Participation

Name of Cooperative MMCAP Infuse Name of Vendor Emergent Devices Inc.

Initial Term of Agency Contract 4/23/2021 - 6/30/2024 Initial Value Indefinite Quantity JPMC

Purchase Method Participation Agency BidBuy

PO#

21-510CPOGS-CPOGS-

P-25955

Agency Change Order Req #

26-510CPOGS-CPOGS-

R-324627

Section II - Change Order Information

1. Provide the original contract description:

The Office of the Chief Procurement Officer for General Services (CPO-GS) is executing an indefinite quantity, joint purchase master contract (JPMC) to enable governmental units and qualified not-for-profit entities to purchase Narcan 4mg Nasal Spray on an as-needed basis.

2. Provide a detailed description and explanation for the change required:

This change order would extend (by 6 months) the State of Illinois' indefinite quantity, joint purchase master contract for the purchase of Narcan through 12/31/26, matching the amended end date of MMCAP Infuse master contract MMS2000303. This is the fourth extension of this contract; the previous end date of both the MMCAP master contract and State of Illinois Participating Addendum was 6/30/26 after extension #3 and 10/31/25 following extension #2.

Since this is an indefinite quantity JPMC, there is not a "not-to-exceed" value on the contract. The current spend on master blanket purchase order 21-510CPOGS-CPOGS-P-25955 is roughly $65M in the 61 months of the contract term. which averages out to about $1.1M per month being spent statewide throughout the term. Therefore, the estimated value of this extension is $9,000,000, which allows for a potential increase in volume by the ordering agencies. Extending this contract will give the permitted users the ability to continue purchasing this critical medication and leveraging the volume-based discounts offered under the MMCAP Infuse master contract.

3. The completion date will be extended, shortened or remain the same.

3.1 Revised Completion Date Dec 31, 2026

4. The Cost will be increased, decreased or remain the same.

4.1 Revised cost N/A

5. The circumstances said to necessitate this change was not reasonably foreseeable at the time the contract was signed.

Yes No The change is germane to the original contract as signed.

Yes No

APPROVAL SIGNATURES

Agency Purchasing Officer Approval

State of Illinois Chief Procurement Office General Services Change Order Request for Participation or Piggyback Contract v.25.1 Page 2 of 2

I know and understand the contents of this Change Order Request and attest that all statements are true and correct.

APO Signature

Printed Name Jan E. Morrow Date Jun 9, 2026

State Purchasing Officer Recommendation Based on my review of the provided information, I agree with the requested change(s) for the following reason(s):

it allows for the continuous purchase of a critically-needed medication at a competitive price point.

SPO Signature

Printed Name Bethany Moore Date Jun 10, 2026

Unified Procurement Program Review and Recommendation Based on my review of the provided information, it is in the best interests of the State to allow the requested change(s) to the existing contract for the following reason(s):

it provides a competitively priced contract vehicle for the uninterrupted access to Narcan, a potentially life-saving medication.

UPP Representative's Signature

Printed Name Andrew Hennig Date Jun 10, 2026

Chief Procurement Officer Approval Based on my review of the provided information, I determine it is in the best interests of the State to allow the requested change(s) to the contract for the following reason(s):

allows agency to continue to have access to Narcan using a competitively priced contract.

Chief Procurement Officer's Signature

Printed Name Ellen H. Daley Date Jun 10, 2026

State of Illinois Chief Procurement Office General Services Change Order Request for Participation or Piggyback Contract v.25.1 Page of Section I - General Information Section II - Change Order Information

1. Provide the original contract description:

2. Provide a detailed description and explanation for the change required:

3. The completion date will be

4. The Cost will be

5. The circumstances said to necessitate this change was not reasonably foreseeable at the time the contract was signed.

The change is germane to the original contract as signed.

APPROVAL SIGNATURES

Agency Purchasing Officer Approval I know and understand the contents of this Change Order Request and attest that all statements are true and correct.

State Purchasing Officer Recommendation Based on my review of the provided information, with the requested change(s) for the following reason(s):

Unified Procurement Program Review and Recommendation Based on my review of the provided information, in the best interests of the State to allow the requested change(s) to the existing contract for the following reason(s):

Chief Procurement Officer Approval Based on my review of the provided information, I determine in the best interests of the State to allow the requested change(s) to the contract for the following reason(s):

6.5.0.20190320.2.935878.932721

Since this is an indefinite quantity JPMC, there is not a "not-to-exceed" value on the contract. The current spend on master blanket purchase order 21-510CPOGS-CPOGS-P-25955 is roughly $65M in the 61 months of the contract term. which averages out to about $1.1M per month being spent statewide throughout the term. Therefore, the estimated value of this extension is $9,000,000, which allows for a potential increase in volume by the ordering agencies. Extending this contract will give the permitted users the ability to continue purchasing this critical medication and leveraging the volume-based discounts offered under the MMCAP Infuse master contract.